Annual FCF
-$214.59 M
-$26.20 M-13.91%
March 31, 2024
Summary
- As of February 12, 2025, IMVT annual free cash flow is -$214.59 million, with the most recent change of -$26.20 million (-13.91%) on March 31, 2024.
- During the last 3 years, IMVT annual FCF has fallen by -$131.05 million (-156.88%).
- IMVT annual FCF is now -301.94% below its all-time high of -$53.39 million, reached on March 31, 2020.
Performance
IMVT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$100.57 M
-$11.73 M-13.20%
December 31, 2024
Summary
- As of February 12, 2025, IMVT quarterly free cash flow is -$100.57 million, with the most recent change of -$11.73 million (-13.20%) on December 31, 2024.
- Over the past year, IMVT quarterly FCF has dropped by -$53.34 million (-112.94%).
- IMVT quarterly FCF is now -25142650.00% below its all-time high of -$400.00, reached on March 31, 2019.
Performance
IMVT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$325.64 M
-$53.34 M-19.59%
December 31, 2024
Summary
- As of February 12, 2025, IMVT TTM free cash flow is -$325.64 million, with the most recent change of -$53.34 million (-19.59%) on December 31, 2024.
- Over the past year, IMVT TTM FCF has dropped by -$115.09 million (-54.66%).
- IMVT TTM FCF is now -81410900.00% below its all-time high of -$400.00, reached on March 31, 2019.
Performance
IMVT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
IMVT Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -13.9% | -112.9% | -54.7% |
3 y3 years | -156.9% | -214.6% | -239.6% |
5 y5 years | -301.9% | - | - |
IMVT Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -156.9% | at low | -397.5% | at low | -239.6% | at low |
5 y | 5-year | -301.9% | at low | -626.4% | at low | -2201.9% | at low |
alltime | all time | -301.9% | at low | <-9999.0% | at low | <-9999.0% | at low |
Immunovant Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | - | -$100.57 M(+13.2%) | -$325.64 M(+19.6%) |
Sep 2024 | - | -$88.84 M(+16.3%) | -$272.30 M(+11.8%) |
Jun 2024 | - | -$76.38 M(+27.6%) | -$243.55 M(+13.5%) |
Mar 2024 | -$214.59 M(+13.9%) | -$59.85 M(+26.7%) | -$214.59 M(+1.9%) |
Dec 2023 | - | -$47.23 M(-21.4%) | -$210.56 M(+0.4%) |
Sep 2023 | - | -$60.09 M(+26.7%) | -$209.82 M(+23.5%) |
Jun 2023 | - | -$47.41 M(-15.1%) | -$169.94 M(-9.8%) |
Mar 2023 | -$188.39 M(+77.1%) | -$55.82 M(+20.1%) | -$188.39 M(+13.7%) |
Dec 2022 | - | -$46.49 M(+130.0%) | -$165.65 M(+9.6%) |
Sep 2022 | - | -$20.22 M(-69.3%) | -$151.12 M(+0.1%) |
Jun 2022 | - | -$65.86 M(+99.1%) | -$151.00 M(+42.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | -$106.37 M(+27.3%) | -$33.07 M(+3.5%) | -$106.37 M(+10.9%) |
Dec 2021 | - | -$31.97 M(+59.1%) | -$95.88 M(+10.5%) |
Sep 2021 | - | -$20.09 M(-5.4%) | -$86.76 M(-4.6%) |
Jun 2021 | - | -$21.23 M(-6.0%) | -$90.92 M(+8.8%) |
Mar 2021 | -$83.54 M(+56.5%) | -$22.59 M(-1.1%) | -$83.54 M(+37.1%) |
Dec 2020 | - | -$22.84 M(-5.8%) | -$60.95 M(+60.0%) |
Sep 2020 | - | -$24.26 M(+75.2%) | -$38.10 M(+169.3%) |
Jun 2020 | - | -$13.85 M(+4492.0%) | -$14.15 M(+2558.1%) |
Mar 2020 | -$53.39 M | - | - |
Sep 2019 | - | -$301.50 K(+30.9%) | -$532.20 K(+130.7%) |
Jun 2019 | - | -$230.30 K(>+9900.0%) | -$230.70 K(>+9900.0%) |
Mar 2019 | - | -$400.00 | -$400.00 |
FAQ
- What is Immunovant annual free cash flow?
- What is the all time high annual FCF for Immunovant?
- What is Immunovant annual FCF year-on-year change?
- What is Immunovant quarterly free cash flow?
- What is the all time high quarterly FCF for Immunovant?
- What is Immunovant quarterly FCF year-on-year change?
- What is Immunovant TTM free cash flow?
- What is the all time high TTM FCF for Immunovant?
- What is Immunovant TTM FCF year-on-year change?
What is Immunovant annual free cash flow?
The current annual FCF of IMVT is -$214.59 M
What is the all time high annual FCF for Immunovant?
Immunovant all-time high annual free cash flow is -$53.39 M
What is Immunovant annual FCF year-on-year change?
Over the past year, IMVT annual free cash flow has changed by -$26.20 M (-13.91%)
What is Immunovant quarterly free cash flow?
The current quarterly FCF of IMVT is -$100.57 M
What is the all time high quarterly FCF for Immunovant?
Immunovant all-time high quarterly free cash flow is -$400.00
What is Immunovant quarterly FCF year-on-year change?
Over the past year, IMVT quarterly free cash flow has changed by -$53.34 M (-112.94%)
What is Immunovant TTM free cash flow?
The current TTM FCF of IMVT is -$325.64 M
What is the all time high TTM FCF for Immunovant?
Immunovant all-time high TTM free cash flow is -$400.00
What is Immunovant TTM FCF year-on-year change?
Over the past year, IMVT TTM free cash flow has changed by -$115.09 M (-54.66%)